1. Signaling Pathways
  2. GPCR/G Protein
    Neuronal Signaling
  3. 5-HT Receptor
  4. 5-HT4 Receptor Isoform

5-HT4 Receptor

 

5-HT4 Receptor Related Products (35):

Cat. No. Product Name Effect Purity
  • HY-14149
    Cisapride
    Agonist 99.72%
    Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM.
  • HY-14153A
    Tegaserod maleate
    Agonist 99.75%
    Tegaserod maleate (SDZ-HTF-919) is an orally active serotonin receptor 4 (HTR4; 5-HT4R) agonist and a 5-HT2B receptor antagonist.
  • HY-B0189A
    Mosapride citrate
    Agonist 99.80%
    Mosapride citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist.
  • HY-15574
    Piboserod
    Antagonist 99.12%
    Piboserod (SB 207266) is a selective 5-HT(4) receptor antagonist.
  • HY-14151
    Prucalopride
    Agonist 99.83%
    Prucalopride is an orally active, selective and specific 5-HT 4 receptor agonist (high affinity), with pKis of 8.6 and 8.1 for human 5-HT4a/4b receptors, respectively.
  • HY-101172
    RS 23597-190
    Antagonist
    RS 23597-190 (EP-A-501322) is a high affinity and selective 5-HT4 receptor antagonist.
  • HY-103152
    GR 113808
    Antagonist 99.96%
    GR 113808 is a potent and highly selective 5-HT4 receptor antagonist (pKb= 8.8).
  • HY-12694
    Prucalopride succinate
    Agonist 99.83%
    Prucalopride succinate is a selective, high affinity 5-HT4 receptor agonist with pKi of 8.6/8.1 for 5-HT4a/4b.
  • HY-14336A
    SB 271046 Hydrochloride
    Antagonist 98.64%
    SB 271046 Hydrochloride (SB 271046A) is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 9.02, 8.55, and 8.81 for rat, pig and human, respectively.
  • HY-18137
    PF-04995274
    Agonist 99.95%
    PF-04995274 is a potent, high-affinity, orally active and partial serotonin 4 receptor (5-HT4R) agonist.
  • HY-10457
    Velusetrag
    Agonist 99.64%
    Velusetrag (TD-5108) is an orally active, potent and selective agonist of serotonin 5-HT4 receptor (5-HT4R), with a pKi of 7.7.
  • HY-101343
    RS 39604
    Antagonist ≥98.0%
    RS 39604 is a potent, selective, and orally active 5-HT4 receptor antagonist with a pKi of 9.1 in guinea pig striatal membranes.
  • HY-102057
    Felcisetrag
    Agonist 99.65%
    Felcisetrag (TD-8954) is an orally active, potent and selective 5-HT4 receptor agonist with gastrointestinal prokinetic properties.
  • HY-U00373
    Revexepride
    Agonist 99.84%
    Revexepride is a highly selective 5-HT4 receptor agonist, and a potential inducer of CYP3A4 enzyme, used for the treatment of gastroesophageal reflux disease.
  • HY-10457A
    Velusetrag hydrochloride
    Agonist
    Velusetrag (TD-5108) hydrochloride is an orally active, potent and selective agonist of serotonin 5-HT4 receptor (5-HT4R), with a pKi of 7.7.
  • HY-16729A
    Relenopride hydrochloride
    Agonist 99.13%
    Relenopride (YKP10811) hydrochloride is a specific and selective 5-HT4 receptor agonist (Ki=4.96 nM).
  • HY-116565
    Usmarapride
    Modulator ≥98.0%
    Usmarapride (SUVN-D4010) is a potent, selective, orally active and brain penetrant 5-HT4 receptor partial agonist (EC50=44 nM).
  • HY-116565A
    Usmarapride free base
    Agonist 99.91%
    Usmarapride (SUVN-D4010) free base is a potent, selective, orally active and brain penetrant 5-HT4 receptor partial agonist (EC50=44 nM).
  • HY-110094
    BIMU 8
    Agonist ≥99.0%
    BIMU 8 is a potent and selective 5-HT4 agonist with EC50s of 18 nM, 77 nM, and 540 nM for wild type 5HT4 receptor, T3.36A, and W6.48A mutant 5-HT4 receptors.
  • HY-105201
    Fabesetron
    Antagonist
    Fabesetron (FK1052) is an orally active 5-HT3 receptor antagonist with 5-HT4 receptor antagonistic activity.